Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
The new project further expands the partner's long-term collaboration on new technologies for R&D
With more than 35 years of experience, Best Formulations is the largest manufacturer of plant-based softgels in the United States, with newly expanded capabilities for nutritional gummies and personal care
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
The centre has initiated next generation sequencing (NGS) as a tool for undertaking studies on genomic epidemiology of pathogens
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Subscribe To Our Newsletter & Stay Updated